Global Meningococcal Group B Vaccine Market Outlook 2022

SKU ID : QYR-19652851 | Publishing Date : 06-Dec-2021 | No. of pages : 91

Detailed TOC of Global Meningococcal Group B Vaccine Market Outlook 2022

1 Meningococcal Group B Vaccine Market Overview
    1.1 Product Overview and Scope of Meningococcal Group B Vaccine
    1.2 Meningococcal Group B Vaccine Segment by Type
        1.2.1 Global Meningococcal Group B Vaccine Sales Growth Rate Comparison by Type (2021-2027)
        1.2.2 Bexsero
        1.2.3 Trumenba
        1.2.4 Other
    1.3 Meningococcal Group B Vaccine Segment by Application
        1.3.1 Global Meningococcal Group B Vaccine Sales Comparison by Application: (2021-2027)
        1.3.2 Public
        1.3.3 Private
    1.4 Global Meningococcal Group B Vaccine Market Size Estimates and Forecasts
        1.4.1 Global Meningococcal Group B Vaccine Revenue 2016-2027
        1.4.2 Global Meningococcal Group B Vaccine Sales 2016-2027
        1.4.3 Meningococcal Group B Vaccine Market Size by Region: 2016 Versus 2021 Versus 2027

2 Meningococcal Group B Vaccine Market Competition by Manufacturers
    2.1 Global Meningococcal Group B Vaccine Sales Market Share by Manufacturers (2016-2021)
    2.2 Global Meningococcal Group B Vaccine Revenue Market Share by Manufacturers (2016-2021)
    2.3 Global Meningococcal Group B Vaccine Average Price by Manufacturers (2016-2021)
    2.4 Manufacturers Meningococcal Group B Vaccine Manufacturing Sites, Area Served, Product Type
    2.5 Meningococcal Group B Vaccine Market Competitive Situation and Trends
        2.5.1 Meningococcal Group B Vaccine Market Concentration Rate
        2.5.2 The Global Top 5 and Top 10 Largest Meningococcal Group B Vaccine Players Market Share by Revenue
        2.5.3 Global Meningococcal Group B Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
    2.6 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Meningococcal Group B Vaccine Retrospective Market Scenario by Region
    3.1 Global Meningococcal Group B Vaccine Retrospective Market Scenario in Sales by Region: 2016-2021
    3.2 Global Meningococcal Group B Vaccine Retrospective Market Scenario in Revenue by Region: 2016-2021
    3.3 North America Meningococcal Group B Vaccine Market Facts & Figures by Country
        3.3.1 North America Meningococcal Group B Vaccine Sales by Country
        3.3.2 North America Meningococcal Group B Vaccine Revenue by Country
        3.3.3 the United States
        3.3.4 Canada
    3.4 Europe Meningococcal Group B Vaccine Market Facts & Figures by Country
        3.4.1 Europe Meningococcal Group B Vaccine Sales by Country
        3.4.2 Europe Meningococcal Group B Vaccine Revenue by Country
        3.4.3 Germany
        3.4.4 France
        3.4.5 UK
        3.4.6 Italy
        3.4.7 Russia
    3.5 Asia Pacific Meningococcal Group B Vaccine Market Facts & Figures by Region
        3.5.1 Asia Pacific Meningococcal Group B Vaccine Sales by Region
        3.5.2 Asia Pacific Meningococcal Group B Vaccine Revenue by Region
        3.5.3 China
        3.5.4 Japan
        3.5.5 South Korea
        3.5.6 India
        3.5.7 Australia
        3.5.8 China Taiwan
        3.5.9 Indonesia
        3.5.10 Thailand
        3.5.11 Malaysia
    3.6 Latin America Meningococcal Group B Vaccine Market Facts & Figures by Country
        3.6.1 Latin America Meningococcal Group B Vaccine Sales by Country
        3.6.2 Latin America Meningococcal Group B Vaccine Revenue by Country
        3.6.3 Mexico
        3.6.4 Brazil
        3.6.5 Argentina
    3.7 Middle East and Africa Meningococcal Group B Vaccine Market Facts & Figures by Country
        3.7.1 Middle East and Africa Meningococcal Group B Vaccine Sales by Country
        3.7.2 Middle East and Africa Meningococcal Group B Vaccine Revenue by Country
        3.7.3 Turkey
        3.7.4 Saudi Arabia
        3.7.5 UAE
4 Global Meningococcal Group B Vaccine Historic Market Analysis by Type
    4.1 Global Meningococcal Group B Vaccine Sales Market Share by Type (2016-2021)
    4.2 Global Meningococcal Group B Vaccine Revenue Market Share by Type (2016-2021)
    4.3 Global Meningococcal Group B Vaccine Price by Type (2016-2021)

5 Global Meningococcal Group B Vaccine Historic Market Analysis by Application
    5.1 Global Meningococcal Group B Vaccine Sales Market Share by Application (2016-2021)
    5.2 Global Meningococcal Group B Vaccine Revenue Market Share by Application (2016-2021)
    5.3 Global Meningococcal Group B Vaccine Price by Application (2016-2021)

6 Key Companies Profiled
    6.1 GSK
        6.1.1 GSK Corporation Information
        6.1.2 GSK Description and Business Overview
        6.1.3 GSK Meningococcal Group B Vaccine Sales, Revenue and Gross Margin (2016-2021)
        6.1.4 GSK Meningococcal Group B Vaccine Product Portfolio
        6.1.5 GSK Recent Developments/Updates
    6.2 Pfizer
        6.2.1 Pfizer Corporation Information
        6.2.2 Pfizer Description and Business Overview
        6.2.3 Pfizer Meningococcal Group B Vaccine Sales, Revenue and Gross Margin (2016-2021)
        6.2.4 Pfizer Meningococcal Group B Vaccine Product Portfolio
        6.2.5 Pfizer Recent Developments/Updates

7 Meningococcal Group B Vaccine Manufacturing Cost Analysis
    7.1 Meningococcal Group B Vaccine Key Raw Materials Analysis
       7.1.1 Key Raw Materials
       7.1.2 Key Suppliers of Raw Materials
    7.2 Proportion of Manufacturing Cost Structure
    7.3 Manufacturing Process Analysis of Meningococcal Group B Vaccine
    7.4 Meningococcal Group B Vaccine Industrial Chain Analysis

8 Marketing Channel, Distributors and Customers
    8.1 Marketing Channel
    8.2 Meningococcal Group B Vaccine Distributors List
    8.3 Meningococcal Group B Vaccine Customers

9 Meningococcal Group B Vaccine Market Dynamics
    9.1 Meningococcal Group B Vaccine Industry Trends
    9.2 Meningococcal Group B Vaccine Growth Drivers
    9.3 Meningococcal Group B Vaccine Market Challenges
    9.4 Meningococcal Group B Vaccine Market Restraints

10 Global Market Forecast
    10.1 Meningococcal Group B Vaccine Market Estimates and Projections by Type
        10.1.1 Global Forecasted Sales of Meningococcal Group B Vaccine by Type (2022-2027)
        10.1.2 Global Forecasted Revenue of Meningococcal Group B Vaccine by Type (2022-2027)
    10.2 Meningococcal Group B Vaccine Market Estimates and Projections by Application
        10.2.1 Global Forecasted Sales of Meningococcal Group B Vaccine by Application (2022-2027)
        10.2.2 Global Forecasted Revenue of Meningococcal Group B Vaccine by Application (2022-2027)
    10.3 Meningococcal Group B Vaccine Market Estimates and Projections by Region
        10.3.1 Global Forecasted Sales of Meningococcal Group B Vaccine by Region (2022-2027)
        10.3.2 Global Forecasted Revenue of Meningococcal Group B Vaccine by Region (2022-2027)

11 Research Finding and Conclusion

12 Methodology and Data Source
    12.1 Methodology/Research Approach
        12.1.1 Research Programs/Design
        12.1.2 Market Size Estimation
        12.1.3 Market Breakdown and Data Triangulation
    12.2 Data Source
        12.2.1 Secondary Sources
        12.2.2 Primary Sources
    12.3 Author List
    12.4 Disclaimer

List of Figures, Tables and Charts Available in Global Meningococcal Group B Vaccine Market Outlook 2022

List of Tables
    Table 1. Global Meningococcal Group B Vaccine Sales (K Units) Growth Rate Comparison by Type (2021-2027)
    Table 2. Global Meningococcal Group B Vaccine Sales (K Units) Comparison by Application (2021-2027)
    Table 3. Global Meningococcal Group B Vaccine Market Size by Region (US$ Million) (2016 VS 2021 VS 2027)
    Table 4. Key Manufacturers Meningococcal Group B Vaccine Covered in This Study
    Table 5. Global Meningococcal Group B Vaccine Sales (K Units) of Key Manufacturers (2016-2021)
    Table 6. Global Meningococcal Group B Vaccine Sales Market Share by Manufacturers (2016-2021)
    Table 7. Global Meningococcal Group B Vaccine Revenue (US$ Million) by Manufacturers (2016-2021)
    Table 8. Global Meningococcal Group B Vaccine Revenue Share by Manufacturers (2016-2021)
    Table 9. Global Market Meningococcal Group B Vaccine Average Price (USD/Unit) of Key Manufacturers (2016-2021)
    Table 10. Manufacturers Meningococcal Group B Vaccine Manufacturing Sites and Area Served
    Table 11. Manufacturers Meningococcal Group B Vaccine Product Type
    Table 12. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 13. Global Meningococcal Group B Vaccine by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Meningococcal Group B Vaccine as of 2020)
    Table 14. Manufacturers Mergers & Acquisitions, Expansion Plans
    Table 15. Global Meningococcal Group B Vaccine Sales by Region (2016-2021) & (K Units)
    Table 16. Global Meningococcal Group B Vaccine Sales Market Share by Region (2016-2021)
    Table 17. Global Meningococcal Group B Vaccine Revenue by Region (2016-2021) & (US$ Million)
    Table 18. North America Meningococcal Group B Vaccine Sales by Country (2016-2021) & (K Units)
    Table 19. North America Meningococcal Group B Vaccine Sales Market Share by Country (2016-2021)
    Table 20. North America Meningococcal Group B Vaccine Revenue by Country (2016-2021) & (US$ Million)
    Table 21. North America Meningococcal Group B Vaccine Revenue Market Share by Country (2016-2021)
    Table 22. Europe Meningococcal Group B Vaccine Sales by Country (2016-2021) & (K Units)
    Table 23. Europe Meningococcal Group B Vaccine Sales Market Share by Country (2016-2021)
    Table 24. Europe Meningococcal Group B Vaccine Revenue by Country (2016-2021) & (US$ Million)
    Table 25. Europe Meningococcal Group B Vaccine Revenue Market Share by Country (2016-2021)
    Table 26. Asia Pacific Meningococcal Group B Vaccine Sales by Region (2016-2021) & (K Units)
    Table 27. Asia Pacific Meningococcal Group B Vaccine Sales Market Share by Region (2016-2021)
    Table 28. Asia Pacific Meningococcal Group B Vaccine Revenue by Region (2016-2021) & (US$ Million)
    Table 29. Asia Pacific Meningococcal Group B Vaccine Revenue Market Share by Region (2016-2021)
    Table 30. Latin America Meningococcal Group B Vaccine Sales by Country (2016-2021) & (K Units)
    Table 31. Latin America Meningococcal Group B Vaccine Sales Market Share by Country (2016-2021)
    Table 32. Latin America Meningococcal Group B Vaccine Revenue by Country (2016-2021) & (US$ Million)
    Table 33. Latin America Meningococcal Group B Vaccine Revenue Market Share by Country (2016-2021)
    Table 34. Middle East and Africa Meningococcal Group B Vaccine Sales by Country (2016-2021) & (K Units)
    Table 35. Middle East and Africa Meningococcal Group B Vaccine Sales Market Share by Country (2016-2021)
    Table 36. Middle East and Africa Meningococcal Group B Vaccine Revenue by Country (2016-2021) & (US$ Million)
    Table 37. Middle East and Africa Meningococcal Group B Vaccine Revenue Market Share by Country (2016-2021)
    Table 38. Global Meningococcal Group B Vaccine Sales (K Units) by Type (2016-2021)
    Table 39. Global Meningococcal Group B Vaccine Sales Market Share by Type (2016-2021)
    Table 40. Global Meningococcal Group B Vaccine Revenue (Million US$) by Type (2016-2021)
    Table 41. Global Meningococcal Group B Vaccine Revenue Share by Type (2016-2021)
    Table 42. Global Meningococcal Group B Vaccine Price (USD/Unit) by Type (2016-2021)
    Table 43. Global Meningococcal Group B Vaccine Sales (K Units) by Application (2016-2021)
    Table 44. Global Meningococcal Group B Vaccine Sales Market Share by Application (2016-2021)
    Table 45. Global Meningococcal Group B Vaccine Revenue (Million US$) by Application (2016-2021)
    Table 46. Global Meningococcal Group B Vaccine Revenue Share by Application (2016-2021)
    Table 47. Global Meningococcal Group B Vaccine Price (USD/Unit) by Application (2016-2021)
    Table 48. GSK Corporation Information
    Table 49. GSK Description and Business Overview
    Table 50. GSK Meningococcal Group B Vaccine Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
    Table 51. GSK Meningococcal Group B Vaccine Product
    Table 52. GSK Recent Developments/Updates
    Table 53. Pfizer Corporation Information
    Table 54. Pfizer Description and Business Overview
    Table 55. Pfizer Meningococcal Group B Vaccine Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
    Table 56. Pfizer Meningococcal Group B Vaccine Product
    Table 57. Pfizer Recent Developments/Updates
    Table 58. Production Base and Market Concentration Rate of Raw Material
    Table 59. Key Suppliers of Raw Materials
    Table 60. Meningococcal Group B Vaccine Distributors List
    Table 61. Meningococcal Group B Vaccine Customers List
    Table 62. Meningococcal Group B Vaccine Market Trends
    Table 63. Meningococcal Group B Vaccine Growth Drivers
    Table 64. Meningococcal Group B Vaccine Market Challenges
    Table 65. Meningococcal Group B Vaccine Market Restraints
    Table 66. Global Meningococcal Group B Vaccine Sales Forecast by Type (2022-2027) & (K Units)
    Table 67. Global Meningococcal Group B Vaccine Sales Market Share Forecast by Type (2022-2027)
    Table 68. Global Meningococcal Group B Vaccine Revenue Forecast by Type (2022-2027) & (US$ Million)
    Table 69. Global Meningococcal Group B Vaccine Revenue Market Share Forecast by Type (2022-2027)
    Table 70. Global Meningococcal Group B Vaccine Sales Forecast by Application (2022-2027) & (K Units)
    Table 71. Global Meningococcal Group B Vaccine Sales Market Share Forecast by Application (2022-2027)
    Table 72. Global Meningococcal Group B Vaccine Revenue Forecast by Application (2022-2027) & (US$ Million)
    Table 73. Global Meningococcal Group B Vaccine Revenue Market Share Forecast by Application (2022-2027)
    Table 74. Global Meningococcal Group B Vaccine Sales Forecast by Region (2022-2027) & (K Units)
    Table 75. Global Meningococcal Group B Vaccine Sales Market Share Forecast by Region (2022-2027)
    Table 76. Global Meningococcal Group B Vaccine Revenue Forecast by Region (2022-2027) & (US$ Million)
    Table 77. Global Meningococcal Group B Vaccine Revenue Market Share Forecast by Region (2022-2027)
    Table 78. Research Programs/Design for This Report
    Table 79. Key Data Information from Secondary Sources
    Table 80. Key Data Information from Primary Sources
List of Figures
    Figure 1. Product Picture of Meningococcal Group B Vaccine
    Figure 2. Global Meningococcal Group B Vaccine Market Share by Type in 2020 & 2027
    Figure 3. Bexsero Product Picture
    Figure 4. Trumenba Product Picture
    Figure 5. Other Product Picture
    Figure 6. Global Meningococcal Group B Vaccine Market Share by Application in 2020 & 2027
    Figure 7. Public
    Figure 8. Private
    Figure 9. Global Meningococcal Group B Vaccine Revenue, (US$ Million), 2016 VS 2021 VS 2027
    Figure 10. Global Meningococcal Group B Vaccine Market Size 2016-2027 (US$ Million)
    Figure 11. Global Meningococcal Group B Vaccine Sales 2016-2027 (K Units)
    Figure 12. Global Meningococcal Group B Vaccine Market Size Market Share by Region: 2016 VS 20210 VS 2027
    Figure 13. Meningococcal Group B Vaccine Sales Share by Manufacturers in 2020
    Figure 14. Global Meningococcal Group B Vaccine Revenue Share by Manufacturers in 2020
    Figure 15. The Global 5 and 10 Largest Meningococcal Group B Vaccine Players: Market Share by Revenue in 2020
    Figure 16. Meningococcal Group B Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2021
    Figure 17. Global Meningococcal Group B Vaccine Sales Market Share by Region (2016-2021)
    Figure 18. Global Meningococcal Group B Vaccine Sales Market Share by Region in 2020
    Figure 19. Global Meningococcal Group B Vaccine Revenue Market Share by Region (2016-2021)
    Figure 20. Global Meningococcal Group B Vaccine Revenue Market Share by Region in 2020
    Figure 21. the United States Meningococcal Group B Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 22. Canada Meningococcal Group B Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 23. Germany Meningococcal Group B Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 24. France Meningococcal Group B Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 25. UK Meningococcal Group B Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 26. Italy Meningococcal Group B Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 27. Russia Meningococcal Group B Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 28. China Meningococcal Group B Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 29. Japan Meningococcal Group B Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 30. South Korea Meningococcal Group B Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 31. India Meningococcal Group B Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 32. Australia Meningococcal Group B Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 33. China Taiwan Meningococcal Group B Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 34. Indonesia Meningococcal Group B Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 35. Thailand Meningococcal Group B Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 36. Malaysia Meningococcal Group B Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 37. Mexico Meningococcal Group B Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 38. Brazil Meningococcal Group B Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 39. Argentina Meningococcal Group B Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 40. Turkey Meningococcal Group B Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 41. Saudi Arabia Meningococcal Group B Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 42. UAE Meningococcal Group B Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 43. Sales Market Share of Meningococcal Group B Vaccine by Type (2016-2021)
    Figure 44. Sales Market Share of Meningococcal Group B Vaccine by Application (2016-2021)
    Figure 45. Sales Market Share of Meningococcal Group B Vaccine by Application in 2020
    Figure 46. Revenue Share of Meningococcal Group B Vaccine by Application (2016-2021)
    Figure 47. Revenue Share of Meningococcal Group B Vaccine by Application in 2020
    Figure 48. Manufacturing Cost Structure of Meningococcal Group B Vaccine
    Figure 49. Manufacturing Process Analysis of Meningococcal Group B Vaccine
    Figure 50. Meningococcal Group B Vaccine Industrial Chain Analysis
    Figure 51. Channels of Distribution
    Figure 52. Distributors Profiles
    Figure 53. Bottom-up and Top-down Approaches for This Report
    Figure 54. Data Triangulation
    Figure 55. Key Executives Interviewed